Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Chiao-Hsu KeKa-Mei SioChun-Hung WuYuan-Yuan XiaJih-Jong LeeChin-Hao HuCheng-Chi LiuChueh-Ling LuChiao-Lei ChengKeng-Hsuan LinHirotaka TomiyasuYu-Shan WangChen-Si LinPublished in: Journal of veterinary internal medicine (2023)
Increased DR-70 concentrations were not affected by tumor type, sex, age, or body weight. However, in dogs with metastatic mast cell tumors and oral malignant melanoma, DR-70 concentrations were significantly increased. Additional studies, including more dogs with nonneoplastic diseases, are needed to further evaluate the usefulness of DR-70 as a tumor biomarker.